abstract |
The invention relates to the use of a composition comprising diazoxide (7-chloro-3-methyl-2H-1,2,4-benzothiadiazine-1,1-dioxide) for the production of a medicament for the treatment and/or prevention of ischemia retinae and diseases associated with an ischemia retinae. The composition used for the above may also contain riluzole, or a derivative thereof with neuroprotective activity or a pharmaceutically-acceptable salt thereof. |